Genmab — Maj 2020

[Helge_LarsenPI-redaktør]

Har lige set det. Tusinde tak.

[Bulder]

Genmab er da lidt med i corona-kapløbet. BMS kører et humax-IL8 studie i pts med både cancer og covid19.

[Sukkeralf]

Pellefh - tror primært det skyldes at de har to store produkter undervejs.....nemlig Tukysa og PADCEV. De er begge spået pæne peaksales hvis jeg husker rigtigt

[Sukkeralf]

kkjoel - det er super

[nohope]

Er der nogen der har indvendinger mod at vi kører GEN i kurs 2000 og deklarerer sommerferie fra i eftermiddag ?

[Bulder]

Godt nok kan covid19 medføre lidt forsinkelser hist og pist. Men meget opløftende, at det ligefrem kan accellerere skiftet fra IV til SC dara.

[kkjoel]

Nohope- det var noget af et "Yes we can!"

[Bulder]

Godt initiv nohope. Bare læg kræfterne i, når du trykker på købsknappen.

[E_L]

@nohope that summerholiday could then last for the rest of the year as far as i am concerned

[E_L]

Do we actually know what the market size is for haemophilia A, for the Novo Duobody MIM-8? I assume they had the first dosing if they got the small milestone

[GeorgeBest]

USD 11.8 billion

Report Overview. The global hemophilia market size was valued at USD 11.8 billion in 2019 and is expected to witness a CAGR of 5.5% over the forecast period. Increasing R&D initiatives especially on identifying therapeutic agents is one the major factors expected to positively impact market growth

[GeorgeBest]

Hemophilia Market Size, Growth Analysis & Industry Trends, 2031

The Hemophilia Market worth USD 15.35 billion in 2026 is growing at a CAGR of 5.4% to reach USD 19.97 billion by 2031. BioMarin Pharmaceutical Inc., CSL Ltd., F. Hoffmann-La Roche AG, Novo Nordisk A/S and Pfizer Inc. are the major companies operating in this market.

Mordor Intelligence (www.mordorintelligence.com)

[GeorgeBest]

January: The first healthy subject was dosed in the Phase I/II study of Mim8

[E_L]

ok, thanks.

[E_L]

the good thing is that if that also works there are plenty here that follow Novo N already to update us lol

[Teller]

Mange mente kurs 2000 var fatamorgana...

[Teller]

Nyt fatamorgana må være 3000, men den tager vi næste år

[Sukkeralf]

Epco data og deal - positve dara data i amyloidosis - positive tiso data i livmoderhalskræft......alt sammen muligt i løbet af 2 måneder !

[Sukkeralf]

Ofa godkendelse i MS ligeså

[Bulder]

va mæ tak-079?